Hoth Historical Income Statement

HOTH Stock  USD 0.84  0.01  1.20%   
Historical analysis of Hoth Therapeutics income statement accounts such as Selling General Administrative of 4.5 M or Total Revenue of 0.0 can show how well Hoth Therapeutics performed in making a profits. Evaluating Hoth Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Hoth Therapeutics's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Hoth Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hoth Therapeutics is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

About Hoth Income Statement Analysis

Hoth Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Hoth Therapeutics shareholders. The income statement also shows Hoth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Hoth Therapeutics Income Statement Chart

As of now, Hoth Therapeutics' Research Development is increasing as compared to previous years. The Hoth Therapeutics' current Total Operating Expenses is estimated to increase to about 8.4 M, while Interest Income is projected to decrease to 741.95.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Hoth Therapeutics. It is also known as Hoth Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Hoth Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.As of now, Hoth Therapeutics' Research Development is increasing as compared to previous years. The Hoth Therapeutics' current Total Operating Expenses is estimated to increase to about 8.4 M, while Interest Income is projected to decrease to 741.95.

Hoth Therapeutics income statement Correlations

-0.82-0.870.820.780.66-0.72-0.770.81-0.540.8-0.510.460.67-0.730.4
-0.820.98-0.99-0.97-0.890.920.98-0.990.14-0.990.57-0.72-0.810.81-0.3
-0.870.98-0.99-0.98-0.870.950.98-0.990.2-0.990.54-0.72-0.830.84-0.31
0.82-0.99-0.990.990.89-0.97-1.01.0-0.111.0-0.530.750.84-0.840.29
0.78-0.97-0.980.990.87-0.97-0.990.99-0.030.99-0.60.650.9-0.850.4
0.66-0.89-0.870.890.87-0.86-0.890.890.140.9-0.70.740.79-0.760.14
-0.720.920.95-0.97-0.97-0.860.98-0.97-0.03-0.970.48-0.74-0.870.84-0.27
-0.770.980.98-1.0-0.99-0.890.98-1.00.06-1.00.52-0.76-0.840.83-0.28
0.81-0.99-0.991.00.990.89-0.97-1.0-0.091.0-0.530.750.85-0.840.29
-0.540.140.2-0.11-0.030.14-0.030.06-0.09-0.08-0.25-0.070.190.12-0.02
0.8-0.99-0.991.00.990.9-0.97-1.01.0-0.08-0.540.750.85-0.840.28
-0.510.570.54-0.53-0.6-0.70.480.52-0.53-0.25-0.54-0.03-0.80.63-0.62
0.46-0.72-0.720.750.650.74-0.74-0.760.75-0.070.75-0.030.35-0.48-0.38
0.67-0.81-0.830.840.90.79-0.87-0.840.850.190.85-0.80.35-0.850.62
-0.730.810.84-0.84-0.85-0.760.840.83-0.840.12-0.840.63-0.48-0.85-0.36
0.4-0.3-0.310.290.40.14-0.27-0.280.29-0.020.28-0.62-0.380.62-0.36
Click cells to compare fundamentals

Hoth Therapeutics Account Relationship Matchups

Currently Active Assets on Macroaxis

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Return On Assets
(0.46)
Return On Equity
(0.83)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.